Histopathological analysis revealed that combined therapy induced tumor stromal remodeling, evidenced by 74% reduction in Ki-67+ proliferating tumor cells (Figure 4F) and 65% decrease in CD163+ M2-like TAMs density (Figure 4G). The gene discussed is CD163; the disease is neoplasm.